Concepedia

John E. Francis

JE

Statistics

Publications

12

Citations

456

H-Index

12

Active since

1962

Affiliations

Novartis (Switzerland)(Current)

University of Oklahoma

Missouri University of Science and Technology

John E. Francis is an author at Novartis (Switzerland) specializing in medicine, pharmacology, and receptor pharmacology.

ORCID

Publications per year

1962–2006

12

Publications

12

Structure-activity profile of a series of novel triazoloquinazoline adenosine antagonists

John E. Francis, William D. Cash, Stacy Psychoyos et al. · Journal of Medicinal Chemistry · 1988 · 153 citations · Full text

, , +6

Synthesis and benzodiazepine binding activity of a series of novel [1,2,4]triazolo[1,5-c]quinazolin-5(6H)-ones

John E. Francis, William D. Cash, Beverly S. Barbaz et al. · Journal of Medicinal Chemistry · 1991 · 74 citations

, , +9

Effect of Optical Thickness on the Directional Transmittance and Emittance of a Dielectric

John E. Francis, T. J. Love · Journal of the Optical Society of America · 1966 · 57 citations

, , +16

Highly selective adenosine A2 receptor agonists in a series of N-alkylated 2-aminoadenosines

John E. Francis, Randy L. Webb, Geetha Ghai et al. · Journal of Medicinal Chemistry · 1991 · 44 citations · Full text

, , +8

CGS 21680: A Potent Selective Adenosine A<sub>2</sub> Receptor Agonist

Randy L. Webb, Matthew A. Sills, James P. Chovan et al. · Cardiovascular Drug Reviews · 1992 · 22 citations

, , +10

1–5 of 12